The Comparative Medicine and Bioimage Centre of Catalonia celebrates its fifth anniversary 17/09/2024 Healthcare Access to innovation Prominent researchers and health professionals shared success stories developed at the centre and discussed the future... Partners - Germans Trias i Pujol Research Institute (IGTP)
We analyze the challenges and opportunities for promoting and developing biotechnological ... 16/09/2024 Healthcare Access to innovation Innovative drugs Industrial biotechnology Financing Proposals such as improving the financing environment for disruptive innovation, startups, and expanding companies, or... AseBio
The Organ-on-Chip Revolution: A Technology Enhancing Drug Development 04/09/2024 Healthcare Access to innovation Organ-on-Chip (OOC) technologies are an innovative approach that replicates human organ structures and functions on... Partners - BeCytes Biotechnologies
Vaxdyn awarded €14.5 Million from the EIC Accelerator to Fund the Clinical Phase of Its Va... 02/09/2024 Healthcare Access to innovation Innovative drugs Antibiotic resistance The European Commission is committed to combating antibiotic resistance through vaccines, selecting Vaxdyn's competitive... Partners - Vaxdyn
European researchers combine physics and biology to develop new biosensors 03/09/2024 Healthcare Access to innovation The result will be an ultra-sensitive biosensor based on DNA origami. Partners - TECNALIA
IDiBE obtains the renewal of its Scientific Unit for Business Innovation by IVACE+I 26/08/2024 Healthcare Access to innovation Partners - IDiBE – UMH (Instituto de Investigación, Desarrollo e innovación en Biotecnología Sanitaria)
Peaches Biotech ready to enter into the production of biological medicines with the Histok... 06/08/2024 Healthcare Access to innovation Innovative drugs Advanced therapies The Madrid-based laboratory, together with Histocell and Cardiva, has launched Histokine, located in the Basque Country... Partners - PEACHES BIOTECH S.L.
ORYZON reports financial results and corporate update for half-year ending June 30, 2024 01/08/2024 Healthcare Access to innovation Innovative drugs Advanced therapies Research and development (R&D) expenses of $4.9m for the half-year ending June 30, 2024. As a result of the completion... Partners - Oryzon Genomics
What is Open Innovation in pharmaceutical R&D? 18/07/2024 Healthcare Access to innovation Drug discovery Innovative drugs The core idea of Open innovation is that companies leverage the ideas and resources of external actors such as customers... Partners - GENESIS Biomed
Integra Therapeutics to receive up to €10.5 million from European Commission for its FiCAT... 17/07/2024 Healthcare Access to innovation Rare diseases Advanced therapies EU projects This funding will enable Integra Therapeutics to launch its first gene therapy to treat a serious pediatric hepatic... Partners - Integra Therapeutics S.L.
